AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 2.55 |
Market Cap | 131.84M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.16 |
PE Ratio (ttm) | -2.29 |
Forward PE | n/a |
Analyst | Hold |
Ask | 2.8 |
Volume | 462,046 |
Avg. Volume (20D) | 573,486 |
Open | 3.01 |
Previous Close | 2.93 |
Day's Range | 2.63 - 3.10 |
52-Week Range | 1.88 - 6.31 |
Beta | undefined |
About AKYA
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze...
Analyst Forecast
According to 7 analyst ratings, the average rating for AKYA stock is "Hold." The 12-month stock price forecast is $3.5, which is an increase of 31.58% from the latest price.
Next Earnings Release
Analysts project revenue of $21.23M, reflecting a -19.85% YoY shrinking and earnings per share of -0.16, making a -27.27% decrease YoY.
2 days ago · https://thefly.com
Quanterix price target lowered by $4 at TD Cowen, here's whyQuanterix + Akoya Biosciences +0.39 (+14.72%)